Finished
PRECISION GRX Post-Market Study - Japan
NCT03870087 · Siemens Healthineers Endovascular Robotics, Inc. · Updated 19 Oct 2020
- What is being tested
- Robotic-assisted PCI
- For
- Coronary Artery Disease
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 20 years and older. About 242 people. The full rules are on the registry page.
- Where
- Japan (8 sites)
- When
- Starts or started 12 April 2019, ends 9 Oct 2020. Registered 11 March 2019.
- Results
- None posted yet.
In the researchers' words
To collect data on the routine patterns of use, safety and effectiveness, including the clinical and technical performance of the CorPath GRX System, in the delivery and manipulation of coronary guidewires and stent/balloon catheters, and manipulation of guide catheters during PCI procedures in the first 231 patients treated with the CorPath device in Japan.
Sites
- Fukuoka Sanno HospitalFukuoka, Fukuoka, Japan
- Kurume University HospitalKurume, Fukuoka, Japan
- Nayoro City General HospitalNayoro, Hokkaido, Japan
- Iwate University HospitalMorioka, Iwate, Japan
- Tokai University HospitalIsehara, Kanagawa, Japan
- Toho University Ohashi Medical CenterTokyo, Ohashi Meguro-ku, Japan
- Dokkyo Medical University HospitalMibu, Tochigi, Japan
- Keio University HospitalShinjuku-ku, Tokyo, Japan